Tag: orphan drugs market share

  • Orphan Drugs Market Growth Potential: Key Insights for 2024-2033

    Orphan Drugs Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Will the Orphan Drugs Market Grow from 2024 to 2033?

    The size of the market for orphan drugs has seen substantial expansion in the recent past. The market is expected to increase from $188.45 billion in 2023 to $208.04 billion in 2024, boasting a compound annual growth rate (CAGR) of 10.4%. The historical growth trajectory can be traced back to factors such as the Orphan Drug Act of 1983, growing attention towards rare diseases, efforts in drug repurposing, advancements in the genetic comprehension, and targeted research funding campaigns.

    The market size of orphan drugs is predicted to experience significant expansion in the coming years. The projection indicates a growth to $481.69 billion by 2028, with a compound annual growth rate (CAGR) of 23.4%. The predicted surge during this period is linked to factors such as changes in market access policies, healthcare initiatives based on value, expansion of the global market, drug development focused on patients, and an emphasis on rare cancers. Trends to look out for during this period include an increase in target identification, expedited regulatory routes, the progression of gene therapy, extensive research collaborations, and precision medicine techniques.

    Claim Your Free Sample of the Global Orphan Drugs Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2823&type=smp

    What Aspects Are Influencing the Growth Rate of the orphan drugs Market?

    The surge in rare disease appearances is a chief factor propelling the development of the orphan drugs market. A rare disease is characterized by its low prevalence in the population. Managing such diseases often hinges on a cold chain, a supply chain that maintains a regulated temperature, but isn’t within easy reach in all nations. Orphan or rare diseases, affecting about 7 people in every 10,000, aren’t common, but their global rate has been escalating in recent past. For instance, an article published in January 2022 by the American Cancer Society stated that there are nearly 54,000 new oropharyngeal or oral cancer cases annually in the USA, leading to about 11,230 deaths. The majority of people diagnosed with these cancers are around 63, but the disease can also affect the younger population. Approximately 20% or 1 in 5 cases are reported in individuals under 55. Hence, the surge in rare disease cases is propelling the development of the orphan drugs market.

    What Are the Critical Segments of the Orphan Drugs Market?

    1) By Therapy Area: Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory

    2) By Diseases Type: Oncology, Hematology, Neurology, Cardiovascular, Other Disease Types

    3) By Drug Type: Biological, Non-Biological

    4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales

    What Trends Are Redefining Consumer Expectations in the Orphan Drugs Market?

    Order Now for Fast Delivery of Your Orphan Drugs Market Report!

    https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

    What Are the Leading Regions in the Orphan Drugs Market Expansion?

    North America was the largest region in the global orphan drugs market in 2023. Middle East is expected to be the fastest growing region in the orphan drugs market report during the forecast period. The regions covered in the orphan drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Orphan Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the orphan drugs market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Orphan Drugs Market Include

    1. Orphan Drugs Market Executive Summary

    2. Orphan Drugs Market Segments

    3. Orphan Drugs Market Size And Template Market Growth Rate

    4. Key Orphan Drugs Market Trends

    5. Major Orphan Drugs Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Orphan Drugs Market

    26. Top Orphan Drugs Companies

    27. Orphan Drugs Market Opportunities And Strategies

    28. Orphan Drugs Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Brain And Neuroimaging Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

    Drugs For Erectile Dysfunction Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

    Orthobiologics Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Takeaways From The Global Orphan Drugs Market Forecast 2024

    Key Takeaways From The Global Orphan Drugs Market Forecast 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Orphan Drugs Global Market Report 2024, the orphan drugs market is expected to show significant growth in the forecast period.

    The orphan drugs market has experienced rapid expansion in recent years, driven by various factors. This blog delves into the current state of the market, future growth projections, key drivers, and emerging trends shaping the landscape of orphan drug development and access.

    Current Market Status and Growth Rate

    • Market Size and Growth:
      • The orphan drugs market is valued at $188.45 billion in 2023 and is projected to reach $208.04 billion in 2024, reflecting a robust CAGR of 10.4%.

    Projected Growth Factors

    • Orphan Drug Act of 1983:
      • The Orphan Drug Act incentivized the development of treatments for rare diseases, spurring investment and innovation in this market segment.
    • Rising Interest in Rare Diseases:
      • Growing awareness and advocacy efforts have heightened interest in rare diseases, driving demand for orphan drugs.
    • Drug Repurposing:
      • Repurposing existing drugs for orphan indications offers a cost-effective strategy for addressing unmet medical needs in rare diseases.
    • Advancements in Genetic Understanding:
      • Improved understanding of the genetic basis of rare diseases has facilitated the development of targeted therapies and personalized medicine approaches.
    • Research Funding Initiatives:
      • Increased funding for rare disease research has accelerated drug discovery and development efforts, expanding the orphan drugs pipeline.

    View More On The Orphan Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

    Future Growth Trends

    • Evolving Market Access Policies:
      • Adaptations in market access policies aim to streamline drug approval processes and enhance patient access to orphan drugs.
    • Value-Based Healthcare Initiatives:
      • Value-based healthcare models prioritize patient outcomes, incentivizing the development of effective orphan drug therapies.
    • Global Market Expansion:
      • Market expansion initiatives aim to address unmet medical needs in underserved regions, driving global access to orphan drugs.
    • Patient-Centric Drug Development:
      • Patient advocacy and involvement in drug development processes promote the development of therapies tailored to patient needs.
    • Targeting Rare Cancers:
      • The focus on rare cancers drives innovation in oncology therapeutics, with a growing emphasis on precision medicine approaches.

    Impact of Rare Disease Prevalence on Market Growth

    • Increasing Prevalence of Rare Diseases:
      • The rising incidence of rare diseases globally underscores the need for innovative orphan drug therapies to address unmet medical needs.
    • Specific Case of Oropharyngeal and Oral Cancer:
      • Oropharyngeal and oral cancer represent significant challenges, with a notable portion of cases occurring in individuals under the age of 55.

    Market Segmentation

    • Therapy Areas:
      • Oncology
      • Blood Disorders
      • Central Nervous System Disorders
      • Endocrine Disorders
      • Cardiovascular Diseases
      • Respiratory Diseases
      • Immunomodulatory Disorders
    • Disease Types:
      • Oncology
      • Hematology
      • Neurology
      • Cardiovascular Diseases
      • Other Rare Disease Types
    • Drug Types:
      • Biological Drugs
      • Non-Biological Drugs
    • Distribution Channels:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Sales

    Regional Insights

    • North America:
      • Emerged as the largest region in the global orphan drugs market in 2023.
    • Middle East:
      • Expected to be the fastest-growing region in the orphan drugs market during the forecast period.

    In conclusion, the orphan drugs market is poised for exponential growth, fueled by regulatory incentives, increasing disease awareness, and advancements in drug development technologies. Embracing patient-centric approaches and expanding market access will be pivotal in addressing the needs of individuals affected by rare diseases worldwide.

    Request A Sample Of The Global Orphan Drugs Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=2823&type=smp